Annual D&A
$5.27 M
+$1.14 M+27.58%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual depreciation & amortization is $5.27 million, with the most recent change of +$1.14 million (+27.58%) on December 31, 2023.
- During the last 3 years, RLAY annual D&A has risen by +$1.72 million (+48.46%).
- RLAY annual D&A is now at all-time high.
Performance
RLAY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.37 M
-$1000.00-0.07%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly depreciation & amortization is $1.37 million, with the most recent change of -$1000.00 (-0.07%) on September 1, 2024.
- Over the past year, RLAY quarterly D&A has increased by +$4000.00 (+0.29%).
- RLAY quarterly D&A is now -2.01% below its all-time high of $1.40 million, reached on March 31, 2024.
Performance
RLAY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5.50 M
+$4000.00+0.07%
September 1, 2024
Summary
- As of February 7, 2025, RLAY TTM depreciation & amortization is $5.50 million, with the most recent change of +$4000.00 (+0.07%) on September 1, 2024.
- Over the past year, RLAY TTM D&A has increased by +$445.00 thousand (+8.79%).
- RLAY TTM D&A is now at all-time high.
Performance
RLAY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RLAY Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.6% | +0.3% | +8.8% |
| 3 y3 years | +48.5% | +35.1% | +44.8% |
| 5 y5 years | +144.6% | +115.6% | +93.5% |
RLAY Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.2% | -2.0% | +43.0% | at high | +40.3% |
| 5 y | 5-year | at high | +85.2% | -2.0% | +60.3% | at high | +93.5% |
| alltime | all time | at high | +144.6% | -2.0% | +115.6% | at high | +725.3% |
Relay Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.37 M(-0.1%) | $5.50 M(+0.1%) |
| Jun 2024 | - | $1.37 M(-1.9%) | $5.50 M(+0.6%) |
| Mar 2024 | - | $1.40 M(+1.5%) | $5.47 M(+3.8%) |
| Dec 2023 | $5.27 M(+27.6%) | $1.38 M(+0.9%) | $5.27 M(+4.1%) |
| Sep 2023 | - | $1.36 M(+2.2%) | $5.06 M(+7.0%) |
| Jun 2023 | - | $1.33 M(+11.4%) | $4.73 M(+8.7%) |
| Mar 2023 | - | $1.20 M(+2.7%) | $4.35 M(+5.4%) |
| Dec 2022 | $4.13 M(+5.2%) | $1.17 M(+12.9%) | $4.13 M(+3.3%) |
| Sep 2022 | - | $1.03 M(+8.1%) | $4.00 M(+0.5%) |
| Jun 2022 | - | $956.00 K(-1.9%) | $3.98 M(-0.1%) |
| Mar 2022 | - | $975.00 K(-5.7%) | $3.98 M(+1.4%) |
| Dec 2021 | $3.92 M | $1.03 M(+2.2%) | $3.92 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $1.01 M(+5.4%) | $3.80 M(+2.7%) |
| Jun 2021 | - | $960.00 K(+4.5%) | $3.70 M(+2.6%) |
| Mar 2021 | - | $919.00 K(+0.8%) | $3.61 M(+1.7%) |
| Dec 2020 | $3.55 M(+24.7%) | $912.00 K(-0.1%) | $3.55 M(+1.7%) |
| Sep 2020 | - | $913.00 K(+5.5%) | $3.49 M(+8.7%) |
| Jun 2020 | - | $865.00 K(+0.7%) | $3.21 M(+5.7%) |
| Mar 2020 | - | $859.00 K(+0.7%) | $3.04 M(+6.7%) |
| Dec 2019 | $2.85 M(+32.1%) | $853.00 K(+34.5%) | $2.85 M(+42.8%) |
| Sep 2019 | - | $634.00 K(-8.2%) | $1.99 M(+46.7%) |
| Jun 2019 | - | $691.00 K(+3.6%) | $1.36 M(+103.6%) |
| Mar 2019 | - | $667.00 K | $667.00 K |
| Dec 2018 | $2.15 M | - | - |
FAQ
- What is Relay Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Relay Therapeutics?
- What is Relay Therapeutics annual D&A year-on-year change?
- What is Relay Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Relay Therapeutics?
- What is Relay Therapeutics quarterly D&A year-on-year change?
- What is Relay Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Relay Therapeutics?
- What is Relay Therapeutics TTM D&A year-on-year change?
What is Relay Therapeutics annual depreciation & amortization?
The current annual D&A of RLAY is $5.27 M
What is the all time high annual D&A for Relay Therapeutics?
Relay Therapeutics all-time high annual depreciation & amortization is $5.27 M
What is Relay Therapeutics annual D&A year-on-year change?
Over the past year, RLAY annual depreciation & amortization has changed by +$1.14 M (+27.58%)
What is Relay Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of RLAY is $1.37 M
What is the all time high quarterly D&A for Relay Therapeutics?
Relay Therapeutics all-time high quarterly depreciation & amortization is $1.40 M
What is Relay Therapeutics quarterly D&A year-on-year change?
Over the past year, RLAY quarterly depreciation & amortization has changed by +$4000.00 (+0.29%)
What is Relay Therapeutics TTM depreciation & amortization?
The current TTM D&A of RLAY is $5.50 M
What is the all time high TTM D&A for Relay Therapeutics?
Relay Therapeutics all-time high TTM depreciation & amortization is $5.50 M
What is Relay Therapeutics TTM D&A year-on-year change?
Over the past year, RLAY TTM depreciation & amortization has changed by +$445.00 K (+8.79%)